Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe website has been updated to version 2.14.1 on January 17, 2025, following the removal of version 2.14.0 on December 20, 2024.SummaryDifference1%
- Check12 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new addition was made on December 20, 2024, while a deletion occurred on November 25, 2024.SummaryDifference0.7%
- Check41 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check48 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check56 days agoChange DetectedA new addition was made on November 25, 2024, while previous content was deleted on October 22, 2024.SummaryDifference0.7%
Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.